The Hawaii State Hospital/PharMerica PGY2 Psychiatric Pharmacy Residency is an ASHP accredited 12-month program with a main purpose of developing highly qualified advanced practitioners in the field of mental health. The program is supported by Hawaii State Hospital in conjunction with PharMerica Corporation.

The main site for this residency program is Hawaii State Hospital. At Hawaii State Hospital the resident will be involved in the following: treatment teams, patient education groups, medication reconciliation, discharge planning, psychopharmacology consults, administrative duties, clozapine and other lab monitoring, and drug information.

Rotations include: Adult inpatient/outpatient, forensic, psychogeriatric, consultative liaison, pharmacy operations/administration. Elective rotations are available.

The resident will precept PharmD students from various universities and participate in disease state topic discussions/journal clubs. Resident will have the opportunity to lecture psych related topics at a local university.

The resident will design and conduct an original research project to be presented in a poster format at the annual conference of the College of Psychiatric and Neurologic Pharmacists (CPNP) to be held in April.

This residency will welcome the resident’s valuable input in expanding clinical pharmacy services to individuals with mental illnesses.